Overexpressed YTHDF2 promotes CDKN1B degradation in an m6A‐dependent manner, enhancing cell proliferation and inhibiting apoptosis, thus reducing ICC cells' sensitivity to cisplatin. This evidence concerns the gene YTHDF2 and intrahepatic cholangiocarcinoma.